Home > Insider Trading > Filing (0001179110-15-007534)

Filing Details

Accession Number:: 0001179110-15-007534
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-05-11 17:04:04
Reporting Period:: 2015-05-07

Filing Date:: 2015-05-11
Accepted Time:: 2015-05-11 17:04:04
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
815094	Abiomed Inc	ABMD	Surgical & Medical Instruments & Apparatus (3841)	042743260

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1286370	R Michael Minogue	C/O Abiomed, Inc., 22 Cherry Hill Drive Danvers MA 01923	President, Ceo, Chairman	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock $.01 Par Value	Acquisiton	2015-05-07	42,798	$11.27	375,270	No	4	M	Direct
Common Stock $.01 Par Value	Disposition	2015-05-07	32,641	$70.00	342,629	No	4	S	Direct
Common Stock $.01 Par Value	Disposition	2015-05-07	5,036	$70.81	337,593	No	4	S	Direct
Common Stock $.01 Par Value	Disposition	2015-05-07	3,215	$71.85	334,378	No	4	S	Direct
Common Stock $.01 Par Value	Disposition	2015-05-07	1,596	$72.98	332,782	No	4	S	Direct
Common Stock $.01 Par Value	Disposition	2015-05-07	310	$73.74	332,472	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2015-05-07	42,798	$0.00	42,798	$11.27

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
42,202	2008-05-30	2017-05-30	No	4	M	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (right to buy)	$13.57	2007-06-01	2016-06-01	82,000	Direct
Common Stock	Stock Option (right to buy)	$13.80	2009-05-23	2018-05-23	43,333	Direct
Common Stock	Stock Option (right to buy)	$18.63	2009-06-15	2018-08-13	76,875	Direct
Common Stock	Stock Option (right to buy)	$5.86	2010-05-28	2019-05-28	146,800	Direct
Common Stock	Stock Option (right to buy)	$5.86	2010-05-28	2019-05-28	56,700	Direct
Common Stock	Stock Option (right to buy)	$10.03	2011-06-03	2020-06-03	105,000	Direct
Common Stock	Stock Option (Right to Buy)	$22.44	2013-05-22	2022-05-22	50,000	Direct
Common Stock	Stock Option (Right to Buy)	$23.15	2014-05-14	2024-05-14	21,250	Direct
Common Stock	Stock Option (right to buy)	$21.55	2015-05-14	2024-05-14	85,000	Direct

Expiration Date	Remaning Holdings	Nature of Ownership
2016-06-01	82,000	Direct
2018-05-23	43,333	Direct
2018-08-13	76,875	Direct
2019-05-28	146,800	Direct
2019-05-28	56,700	Direct
2020-06-03	105,000	Direct
2022-05-22	50,000	Direct
2024-05-14	21,250	Direct
2024-05-14	85,000	Direct

Footnotes

Grant to reporting person of option to buy shares of Common Stock under the ABIOMED, Inc. 2000 Stock Incentive Plan.
These options become exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6.
Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
These options become exercisable based on the achievement of certain performance milestones.
Sale of common stock pursuant to reporting owner's 10b5-1 plan.
This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $69.5000 and $70.4900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $70.5000 and $71.3800. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $71.5200 and $72.3400. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $72.3900 and $73.3400. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $73.4100 and $73.9000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.